EUVIMEDEUVIMED entdecken
Open Access · CC BY 2.0

Antigenized antibodies expressing Vβ8.2 TCR peptides immunize against rat experimental allergic encephalomyelitis

Cristina Musselli, Svetlana Daverio-Zanetti, Maurizio Zanetti

Journal of Immune Based Therapies and Vaccines · 2004

DOI: 10.1186/1476-8518-2-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Immune Based Therapies and Vaccines, 2004. Verfasst von Cristina Musselli und 2 weiteren Autor:innen. Beteiligte Einrichtung: The Department of Medicine and Cancer Center, University of California, San Diego, La Jolla CA USA. mzanetti@ucsd.edu. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 2.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Immunity against the T cell receptor (TCR) is considered to play a central role in the regulation of experimental allergic encephalomyelitis (EAE), a model system of autoimmune disease characterized by a restricted usage of TCR genes. Methods of specific vaccination against the TCR of pathogenetic T cells have included attenuated T cells and synthetic peptides from the sequence of the TCR. These approaches have led to the concept that anti-idiotypic immunity against antigenic sites of the TCR, which are a key regulatory element in this disease.

Methods

The present study in the Lewis rat used a conventional idiotypic immunization based on antigenized antibodies expressing selected peptide sequences of the Vβ8.2 TCR ( 93 ASSDSSNTE 101 and 39 DMGHGLRLIHYSYDVNSTEKG 59 ).

Results

The study demonstrates that vaccination with antigenized antibodies markedly attenuates, and in some instances, prevents clinical EAE induced with the encephalitogenic peptide 68 GSLPQKSQRSQDENPVVHF 88 in complete Freunds' adjuvant (CFA). Antigenized antibodies induced an anti-idiotypic response against the Vβ8.2 TCR, which was detected by ELISA and flowcytometry. No evidence was obtained of a T cell response against the corresponding Vβ8.2 TCR peptides.

Conclusions

The results indicate that antigenized antibodies expressing conformationally-constrained TCR peptides are a simple means to induce humoral anti-idiotypic immunity against the TCR and to vaccinate against EAE. The study also suggests the possibility to target idiotypic determinants of TCR borne on pathogenetic T cells to vaccinate against disease.

Autor:innen und Institutionen

  • The Department of Medicine and Cancer Center, University of California, San Diego, La Jolla CA USA. mzanetti@ucsd.edu.

Zitieren

APA

Musselli, C., Daverio-Zanetti, S., & Zanetti, M. (2004). Antigenized antibodies expressing Vβ8.2 TCR peptides immunize against rat experimental allergic encephalomyelitis. Journal of Immune Based Therapies and Vaccines. https://doi.org/10.1186/1476-8518-2-9

Vancouver

Musselli C, Daverio-Zanetti S, Zanetti M. Antigenized antibodies expressing Vβ8.2 TCR peptides immunize against rat experimental allergic encephalomyelitis. Journal of Immune Based Therapies and Vaccines. 2004. doi:10.1186/1476-8518-2-9

BibTeX
@article{Musselli2004,
  author = {Musselli, Cristina and Daverio-Zanetti, Svetlana and Zanetti, Maurizio},
  title = {Antigenized antibodies expressing Vβ8.2 TCR peptides immunize against rat experimental allergic encephalomyelitis},
  journal = {Journal of Immune Based Therapies and Vaccines},
  year = {2004},
  doi = {10.1186/1476-8518-2-9}
}
Kostenlos starten →